2
Training Days 2009 New Drugs Development in Paediatric Oncology ITCC Educational Task Force … Hubertus N. Caron François Doz Darren Hargrave Riccardo Riccardi Chairman Gilles Vassal Faculty … Joachim Boos Münster, DE Renaud Capdeville Basel, CH Dominique Couanet Villejuif, FR Hubertus N. Caron Amsterdam, NL François Doz Paris, FR Birgit Geoerger Villejuif, FR • ITCC, European no-profit Consortium, is pleased to announce the 2nd ITCC Training Course devoted to early drug development in paediatric patients with cancer. • This course is a clinically-oriented educational programme designed for paediatric oncologists who wish to improve their skills in the conduct of early clinical trials. • The course offers plenary lectures on state-of-the-art and practical workshop sessions • It is addressed to doctors and research nurses working in ITCC centres. However motivated paediatric oncologists from other institutions, including personnel from pharmaceutical companies, may apply. 40 participants will be admitted. Selection will be made on the basis of personal CV (visit www.ptsroma.it/itcc2009) Course Venue Catholic University of Rome Largo A. Gemelli 8, 00168 Rome, Italy Room “Brasca”, Floor 4 Registration to the Course Registration fees 500,00 + 20% VAT for academia a Post Graduate Course October 22-24, 2009 Catholic University, Rome, Italy Birgit Geoerger Villejuif, FR Darren Hargrave Sutton, UK Janez Jazbec Ljubljana, SL Pamela Kearnes Bristol, UK Marie Cécile Le Deley Villejuif, FR Bruce Morland Birmingham, UK Herbert Newell London, UK Kathy Pritchard-Jones Sutton, UK Riccardo Riccardi Roma, IT Gilles Vassal Villejuif, FR Gareth Veal Newcastle upon Tyne, UK Arnaud Verschurr Amsterdam, NL Louis Viviers Basel, CH Acknowledgements 500,00 + 20% VAT for academia 1500,00 + 20% VAT for non academic applications VAT is compulsory for EU citizens Registration fee includes • Attendance in the scientific sessions •Coffee breaks and working lunches • 3 nights hotel accomodation Cancellation. No refund allowed. name change is permitted prior to October 1, 2009 Organizing Secretariat PTS Congress – Maura Stella Via Nizza, 45 – 00198 Roma (Italy) Phone: +39-06-8535-5590 Fax: +39-06-8535-6060 e-mail: [email protected] Course Secretariat Sara Calmanti Sonia Terella Mirella Oddi

Training Days 2009 - AIEOP · Joachim Boos Münster, DE Renaud Capdeville Basel, CH Dominique Couanet Villejuif, FR Hubertus N. Caron Amsterdam, NL François Doz Paris, FR Birgit

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Training Days 2009 - AIEOP · Joachim Boos Münster, DE Renaud Capdeville Basel, CH Dominique Couanet Villejuif, FR Hubertus N. Caron Amsterdam, NL François Doz Paris, FR Birgit

Training Days 2009New Drugs Development

in Paediatric Oncology

ITCC Educational Task Force …

Hubertus N. Caron

François Doz

Darren Hargrave

Riccardo Riccardi Chairman

Gilles Vassal

Faculty …

Joachim Boos Münster, DE

Renaud Capdeville Basel, CH

Dominique Couanet Villejuif, FR

Hubertus N. Caron Amsterdam, NL

François Doz Paris, FR

Birgit Geoerger Villejuif, FR

• ITCC, European no-profit Consortium, is pleased to announcethe 2nd ITCC Training Course devoted to early drugdevelopment in paediatric patients with cancer.

• This course is a clinically-oriented educationalprogramme designed for paediatric oncologists who wish toimprove their skills in the conduct of early clinical trials.

• The course offers plenary lectures on state-of-the-artand practical workshop sessions

• It is addressed to doctors and research nurses working inITCC centres. However motivated paediatric oncologists fromother institutions, including personnel from pharmaceuticalcompanies, may apply.

• 40 participants will be admitted. Selection will be madeon the basis of personal CV (visit www.ptsroma.it/itcc2009)

Course VenueCatholic University of Rome

Largo A. Gemelli 8, 00168 Rome, ItalyRoom “Brasca”, Floor 4

Registration to the CourseRegistration fees

€ 500,00 + 20% VAT for academiain Paediatric Oncologya Post Graduate Course

October 22-24, 2009Catholic University, Rome, Italy

Birgit Geoerger Villejuif, FR

Darren Hargrave Sutton, UK

Janez Jazbec Ljubljana, SL

Pamela Kearnes Bristol, UK

Marie Cécile Le Deley Villejuif, FR

Bruce Morland Birmingham, UK

Herbert Newell London, UK

Kathy Pritchard-Jones Sutton, UK

Riccardo Riccardi Roma, IT

Gilles Vassal Villejuif, FR

Gareth Veal Newcastle upon Tyne, UK

Arnaud Verschurr Amsterdam, NL

Louis Viviers Basel, CH

Acknowledgements

€ 500,00 + 20% VAT for academia€ 1500,00 + 20% VAT for non academic applications

VAT is compulsory for EU citizens

Registration fee includes• Attendance in the scientific sessions•Coffee breaks and working lunches

• 3 nights hotel accomodationCancellation.

No refund allowed. name change is permittedprior to October 1, 2009

Organizing Secretariat

PTS Congress – Maura Stella

Via Nizza, 45 – 00198 Roma (Italy)

Phone: +39-06-8535-5590

Fax: +39-06-8535-6060

e-mail: [email protected]

Course Secretariat

Sara Calmanti

Sonia Terella

Mirella Oddi

Page 2: Training Days 2009 - AIEOP · Joachim Boos Münster, DE Renaud Capdeville Basel, CH Dominique Couanet Villejuif, FR Hubertus N. Caron Amsterdam, NL François Doz Paris, FR Birgit

22 OctoberChair: R. Riccardi

16.00-16.10 Welcome R. Riccardi

16.10-17.00 Lecture Strategy for thedevelopment of theInnovative Therapiesfor Children withCancer

G. Vassal

17.00-18.00 Lecture Role of biology andpreclinical evaluation

H. Caron

ITCC Training Course: New Drugs Development in Paediatric Oncology

S c i e n t i f i c P r o g r a m m e

23 OctoberChair: D. Hargrave

08.30-09.30 Lecture Design and conductof phase I studies:from MTD to OBD

B. Geoerger

09.30-10.30 Lecture Coordination ofpharmacokineticsstudies in apaediatric patientpopulation

G. Veal

10.30-11.00 Coffee break

11.00-13.00 WorkshopGroupSession

Protocoldevelopment: phase Itrials

D. HargraveB. GeoergerA. Verschuur

13.00-14.00 Lunch

24 OctoberChair: B. Morland

08.00-08.30 Keynote Introducing innovativetherapies in thestandard care ofchildren with cancer inEurope

K. PritchardJones

08.30-09.15 Lecture How to conduct aphase II trial

B. Morland

9.15-9.45 Lecture Early clinical studies inleukaemia

P. Kearnes

09.45-10.30 Keynote Biomarkers inanticancer drugdevelopment

H. Newell

10.30-11.00 Coffee break

11.00-13.00 WorkshopGroupSession

Protocol development:phase II trials

B. MorlandP. KearnesF. Doz

13.00-14.30 Lunch

preclinical evaluationin anticancer drugdevelopment forchildren

18.00-19.00 Keynote Role of paediatricinvestigational plans innew drug development

J. Jazbec

Chair: F. Doz

14.00-14.45 Lecture Pharmacovigilancein paediatriconcology trials

J. Boos

14.45-16.30 Interactivesession

How to propose anearly clinical trial topatients and parents

F. DozR. Riccardi

16.30-17.00 Coffee break

17.00-17.45

17.45-18.30

Workshop

Keynote

New design andmethodology forearly clinical trials inchildren

Integration of clinicalresearch and drugdevelopment

M.C. Le Deley

R. Capdeville

Chair: G. Vassal

14.30-15.30 Keynote Comprehensiveimaging in paediatriconcology: use of righttools for innovativetreatment

D. Couanet

15.30-16.15 Interactivesession

Case studies: tumourresponsemeasurement

D. CouanetR. RiccardiD. Hargrave

16.15-16.45 Coffee break

16.45-17.15 Keynote Academia-Pharmacollaboration inpaediatric oncology

L. Viviers

17.15-18.00 Paneldiscussionwith theparticipants

Partnership inbetweenPharma-Regulators-Academia

L. ViviersH. NewellG. Vassal